{"status": "OK", "response": {"docs": [{"type_of_material": "News", "blog": [], "news_desk": "Business/Financial Desk", "lead_paragraph": "People who hope to slim down with the help of Xenical, a newly approved weight-loss drug, may have to pay for it themselves. A number of managed care companies are categorizing Xenical as a life style product that they will cover only in exceptional cases -- for overweight people at risk for cardiovascular problems, or those with diabetes, breathing problems or brittle bones. Even so, analysts said, many people are likely to pay the $4 or $5 a day themselves needed to buy Xenical, a treatment made by Roche Holding A.G. of Switzerland. Analysts projected peak worldwide sales of the drug at $600 million to as much as $3 billion a year.", "headline": {"main": "Diet Drug May Face A Tough Sell At H.M.O.'s"}, "abstract": "Several managed care companies categorize Xenical, newly approved weight-loss drug, as life style product that they will cover only in exceptional cases, for overweight people at risk of cardiovascular problems or other serious problems; analysts expect many people to pay for Xenical themselves, at cost of $4 or $5 per day (M)", "print_page": "6", "word_count": 711, "_id": "4fd1ff408eb7c8105d760e52", "snippet": "People who hope to slim down with the help of Xenical, a newly approved weight-loss drug, may have to pay for it themselves. A number of managed care companies are categorizing Xenical as a life style product that they will cover only in exceptional...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/1999/05/03/business/diet-drug-may-face-a-tough-sell-at-hmo-s.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "subject", "value": "WEIGHT"}, {"name": "subject", "value": "HEALTH MAINTENANCE ORGANIZATIONS AND MANAGED CARE"}, {"name": "subject", "value": "HEALTH INSURANCE"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "PRICES (FARES, FEES AND RATES)"}, {"name": "subject", "value": "XENICAL (DRUG)"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Milt", "lastname": "FREUDENHEIM"}], "original": "By MILT FREUDENHEIM"}, "document_type": "article", "pub_date": "1999-05-03T00:00:00Z", "section_name": "Health; Business"}], "meta": {"hits": 1, "offset": 0, "time": 36}}, "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved."}